Breast Cancer has been the subject of sustained clinical investigation across multiple research sites.

62 total trials for this combination

Showing top 10 of 62 trials

Trials

NCT ID	Title	Status	Phase
NCT02568267	Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)	ACTIVE_NOT_RECRUITING	PHASE2
NCT05708950	A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)	UNKNOWN	PHASE1/PHASE2
NCT03488693	Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer	RECRUITING	PHASE3
NCT02574455	Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)	COMPLETED	PHASE3
NCT00863655	Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole	COMPLETED	PHASE3
NCT02120417	A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer	TERMINATED	PHASE2
NCT05896189	Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors	RECRUITING	NA
NCT04478266	Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer	TERMINATED	PHASE3
NCT06760637	Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease	RECRUITING	PHASE3
NCT00829166	A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer	COMPLETED	PHASE3

Related Pages

All Breast Cancer trials All trials in santa monica, united states